Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: A single-arm phase 2 trial

1. source data: The source data includes de-identified raw data from this clinical study, covering patients' baseline information, disease progression or death status, and tumor response. It also includes data from translational research, such as cytokine data and multiplex immunofluorescence staining data.
2. Supplemental Data 1: List of antibody clones utilized for flow cytometry are included in Supplementary Data 1.